Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Sirolimus Vs. Tacrolimus As The Primary Agent In Immunosuppressive Regimen For African-American Renal Allograft Recipients With Immediate Graft Function: A Pilot Study

NCT00252655 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.

NCT NCT00252655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Sirolimus Vs. Tacrolimus As The Primary Agent In Immunosuppressive Regimen For African-American Renal Allograft Recipients With Immediate Graft Function: A Pilot Study
Lead sponsor
Wayne State University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2004
Completion date
June 30, 2009
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation